Milkiewicz, Piotr
17 papers on CoChatORCID 0000-0002-1817-0724
Most cited papers
- Verified
Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis
Weismüller, T. J., Trivedi, P. J., Bergquist, A., Imam, M., Lenzen, H., Ponsioen, C. Y., Holm, K., Gotthardt, D., Färkkilä, M. A., Marschall, H.-U., et al. (2017) · Gastroenterology
Liver Diseases and ImmunityInflammatory Bowel Disease
Cited by 533
- Verified
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis
The UK-PSCSC Consortium, Liu, J. Z., The International IBD Genetics Consortium, The International PSC Study Group, Hov, J. R., Folseraas, T., Ellinghaus, E., Rushbrook, S. M., Doncheva, N. T., Andreassen, O. A., et al. (2013) · Nature Genetics
Liver Diseases and ImmunityGenetic Associations and Epidemiology
Cited by 391
- Verified
Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease
The UK-PSC Consortium, Ji, S.-G., The International IBD Genetics Consortium, The International PSC Study Group, Juran, B. D., Mucha, S., Folseraas, T., Jostins, L., Melum, E., Kumasaka, N., et al. (2017) · Nature Genetics
Liver Diseases and ImmunityGenetic Associations and Epidemiology
Cited by 357
- Verified
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways
Cordell, H. J., Han, Y., Mells, G. F., Li, Y., Hirschfield, G. M., Greene, C. S., Xie, G., Juran, B. D., Zhu, D., Qian, D. C., et al. (2015) · Nature Communications
Liver Diseases and ImmunityGenetic Associations and Epidemiology
Cited by 287
- Verified
Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis
Hirschfield, G. M., Liu, X., Han, Y., Gorlov, I. P., Lu, Y., Xu, C., Lu, Y., Chen, W., Juran, B. D., Coltescu, C., et al. (2010) · Nature Genetics
Liver Diseases and ImmunityGenetic Associations and Epidemiology
Cited by 215
- Verified
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants
Juran, B. D., Hirschfield, G. M., Invernizzi, P., Atkinson, E. J., Li, Y., Xie, G., Kosoy, R., Ransom, M., Sun, Y., Bianchi, I., et al. (2012) · Human Molecular Genetics
Liver Diseases and ImmunityGenetic Associations and Epidemiology
Cited by 150
- Verified
PBC Screen: An IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis
Liu, H., Norman, G. L., Shums, Z., Worman, H. J., Krawitt, E. L., Bizzaro, N., Vergani, D., Bogdanos, D. P., Dalekos, G. N., Milkiewicz, P., et al. (2010) · Journal of Autoimmunity
Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments
Cited by 130
- Verified
Anti‐kelch‐like 12 and anti‐hexokinase 1: novel autoantibodies in primary biliary cirrhosis
Norman, G. L., Yang, C., Ostendorff, H. P., Shums, Z., Lim, M. J., Wang, J., Awad, A., Hirschfield, G. M., Milkiewicz, P., Bloch, D. B., et al. (2015) · Liver International
Liver Diseases and ImmunityAutoimmune Bullous Skin Diseases
Cited by 87
- Verified
Association of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genes
Hirschfield, G. M., Xie, G., Lu, E., Sun, Y., Juran, B. D., Chellappa, V, Coltescu, C., Mason, A. L., Milkiewicz, P., Myers, R. P., et al. (2012) · Genes & Immunity
Liver Diseases and ImmunityGenetic Associations and Epidemiology
Cited by 85
- Verified
Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study
de Vries, E. M. G., Färkkilä, M., Milkiewicz, P., Hov, J. R., Eksteen, B., Thorburn, D., Chazouillères, O., Pares, A., Nygård, S., Gilja, O. H., et al. (2017) · Liver International
Liver Diseases and ImmunityLiver Disease Diagnosis and Treatment
Cited by 83
- Verified
TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation
Labiano, I., Agirre-Lizaso, A., Olaizola, P., Echebarria, A., Huici-Izagirre, M., Olaizola, I., Esparza-Baquer, A., Sharif, O., Hijona, E., Milkiewicz, P., et al. (2022) · Journal of Hepatology
Liver Diseases and ImmunityLiver physiology and pathology
Cited by 78
- Verified
Assessment of health related quality of life in polish patients with primary biliary cirrhosis
Raszeja-Wyszomirska, J., Wunsch, E., Krawczyk, M., Rigopoulou, E. I., Kostrzewa, K., Norman, G. L., Bogdanos, D. P., & Milkiewicz, P. (2016) · Clinics and Research in Hepatology and Gastroenterology
Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments
Cited by 47
- Verified
Fine‐Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease
Blokker, B. A., Maijo, M., Echeandia, M., Galduroz, M., Patterson, A. M., Ten, A., Philo, M., Schungel, R., Gutierrez‐de Juan, V., Halilbasic, E., et al. (2019) · Hepatology
Sirtuins and Resveratrol in MedicineLiver physiology and pathology
Cited by 46
- Verified
Anti-glycoprotein 2 (anti-GP2) IgA and anti-neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3-ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitis
Wunsch, E., Norman, G. L., Milkiewicz, M., Krawczyk, M., Bentow, C., Shums, Z., Mahler, M., Lopens, S., Reinhold, D., Franke, A., et al. (2021) · Alimentary Pharmacology & Therapeutics
Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments
Cited by 43
- Verified
Prospective evaluation of PBC ‐specific health‐related quality of life questionnaires in patients with primary sclerosing cholangitis
Raszeja‐Wyszomirska, J., Wunsch, E., Krawczyk, M., Rigopoulou, E. I., Bogdanos, D., & Milkiewicz, P. (2015) · Liver International
Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments
Cited by 43
- Verified
Common functional alterations identified in blood transcriptome of autoimmune cholestatic liver and inflammatory bowel diseases
Ostrowski, J., Goryca, K., Lazowska, I., Rogowska, A., Paziewska, A., Dabrowska, M., Ambrozkiewicz, F., Karczmarski, J., Balabas, A., Kluska, A., et al. (2019) · Scientific Reports
Liver Diseases and ImmunityInflammatory Bowel Disease
Cited by 36
- Verified
THU-095 Novel machine learning algorithm for risk prediction of cholangiocarcinoma in primary sclerosing cholangitis
Wunsch, E., Horecki, M., Milkiewicz, M., Kruk, B., Fischer, K., Winikajtis-Burzyńska, A., Norman, G., Roggenbuck, D., & Milkiewicz, P. (2024) · Journal of Hepatology
Liver Diseases and ImmunityCholangiocarcinoma and Gallbladder Cancer Studies
Cited by 1
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free